Zobrazeno 1 - 10
of 45
pro vyhledávání: '"R C, Flanigan"'
Publikováno v:
Aktuelle Urologie. 46:429-430
Publikováno v:
Journal of Surgical Oncology. 46:235-240
Definitive treatment of localized carcinoma of the prostate has included radical surgery, external beam radiation therapy, and interstitial radiation therapy. The interstitial agent most commonly used is Iodine-125. Forty-eight patients were treated
Autor:
S E, Eggener, J N, Rubenstein, N D, Smith, R B, Nadler, J, Kontak, R C, Flanigan, W B, Waters, M, Picken, S C, Campbell, J R, Rubenstein
Publikováno v:
The Journal of urology. 171(1)
The clinical and pathological features of solid or complex cystic renal masses in young adults have not been defined. We present our experience with patients 17 to 45 years old with such renal masses to define the incidence of malignant vs benign les
Autor:
L E., Schroder, D, Lew, R C., Flanigan, M A., Eisenberger, T E., Seay, N, Hammond, B M., Needles, E D., Crawford
Publikováno v:
Urologic oncology. 6(4)
Twenty-two eligible patients with advanced renal carcinoma were treated with suramin utilizing a fixed dose regimen. Therapy was reasonably well tolerated with 3 of 22 patients (14%) developing grade 4 toxicity and 11 of 22 patients (50%) having a ma
Autor:
R C, Flanigan, P M, Yonover
Publikováno v:
Seminars in urologic oncology. 19(2)
The role of cytoreductive surgery in patients with metastatic renal cancer remains controversial. Recent data from our Southwest Oncology Group trial suggest that cytoreduction confers an approximately 50% increase in median survival for such patient
Publikováno v:
The Journal of urology. 164(6)
The consumption of various fatty acids has been associated with advanced stage and fatal prostate cancer. While numerous mechanisms have been postulated, to our knowledge there physiological data linking exposure and prognosis in humans are lacking.
Publikováno v:
The Journal of urology. 164(6)
We identify predictors of extraprostatic extension and positive surgical margins in patients with low risk prostate cancer (prostate specific antigen [PSA] 10 ng./ml. or less, biopsy Gleason score 7 or less and clinical stage T1c-2b).From August 1997
Autor:
L, Elias, D, Lew, R A, Figlin, R C, Flanigan, M E, Thompson, P L, Triozzi, R J, Belt, D P, Wood, S E, Rivkin, E, David
Publikováno v:
Cancer. 89(3)
A Phase II trial was conducted to determine the response rate of patients with advanced renal cell carcinoma to a three-drug combination of 5-fluorouracil (5-FU), interleukin-2 (IL-2), and interferon-alpha-2b (IFN-alpha).A 2-stage accrual plan was us
Autor:
J M, Hafron, R C, Flanigan
Publikováno v:
Techniques in urology. 6(1)
Amyloidosis of the ureter is a rare condition. It is even rarer when it involves both the ureter and bladder. The case presented is the second known case of combined amyloidosis of the bladder and ureter and the first combined case to be treated succ
Publikováno v:
Diagnostic cytopathology. 22(2)
DNA analysis is becoming an important diagnostic and prognostic adjunct test in urinary cytology. The aim of this study was to compare the results of DNA flow cytometry (FCM) with the cytologic diagnosis of bladder washings (BW). DNA ploidy was evalu